Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTRE: Complete Neoadjuvant Treatment for Rectal Cancer
NCT01363843Phase 2Completed
- Start
- May 2010
- Primary completion
- Jan 2013
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, folinic acid, fluorouracil in rectal cancer. Started May 2010; status: completed.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01363843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363843.